News
Pay to Play? Pharma Giant Admits Michael Cohen Offered Access to Trump for Cash

A new report from Stat News reveals that longtime Trump “fixer” Michael Cohen promised pharmaceutical giant Novartis direct access to President Donald Trump in exchange for cash.
According to a source within the company, Cohen approached them last year and let them know he could set up meetings between the company and Trump administration officials, including the president himself.
“He reached out to us,” the source claimed. “With a new administration coming in, basically, all the traditional contacts disappeared and they were all new players. We were trying to find an inroad into the administration. Cohen promised access to not just Trump, but also the circle around him. It was almost as if we were hiring him as a lobbyist.”
Of course, Cohen is not a registered lobbyist, which could put the company’s payment to him in murky legal territory.
Additionally, Stat News’ source would not explain why it agreed to pay Cohen a full $1.2 million without proof that he could really deliver access to Trump, since he did not have a background in health care or deep contacts in Washington DC.
As it turned out, Cohen could not secure Novartis the access it desired, meaning it spent over a million dollars for nothing.
“This episode was clearly a mistake,” Stat News’ source says.
Enjoy this piece?
… then let us make a small request. The New Civil Rights Movement depends on readers like you to meet our ongoing expenses and continue producing quality progressive journalism. Three Silicon Valley giants consume 70 percent of all online advertising dollars, so we need your help to continue doing what we do.
NCRM is independent. You won’t find mainstream media bias here. From unflinching coverage of religious extremism, to spotlighting efforts to roll back our rights, NCRM continues to speak truth to power. America needs independent voices like NCRM to be sure no one is forgotten.
Every reader contribution, whatever the amount, makes a tremendous difference. Help ensure NCRM remains independent long into the future. Support progressive journalism with a one-time contribution to NCRM, or click here to become a subscriber. Thank you. Click here to donate by check.
![]() |